A DNA vaccine encoding a single-chain trimer of HLA-A2 linked to human mesothelin peptide generates anti-tumor effects against human mesothelin-expressing tumors

被引:52
作者
Hung, Chien-Fu
Calizo, Roanne
Tsai, Ya-Chea
He, Liangmei
Wu, T-C
机构
[1] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA
[2] Johns Hopkins Med Inst, Dept Obstet & Gynecol, Baltimore, MD 21205 USA
[3] Johns Hopkins Med Inst, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA
[4] Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21205 USA
关键词
DNA vaccine; immunotherapy; human mesothelin; single-chain trimer;
D O I
10.1016/j.vaccine.2006.06.087
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mesothelin is highly expressed in a majority of ovarian cancer cells and is expressed at low levels in normal cells. Therefore, mesothelin represents a potential target antigen for ovarian cancer vaccine development. DNA vaccines employing single-chain trimers (SCT) have been shown to bypass antigen processing and presentation and result in significant enhancement of DNA vaccine potency. In the current study, we created a DNA vaccine employing an SCT targeting human mesothelin and characterized the ensuing antigen-specific CD8(+) T cell-mediated immune responses and anti-tumor effects against human mesothelin-expressing tumors in HLA-A2 transgenic mice. Our results showed that vaccination with DNA employing an SCT of HLA-A2 linked to human mesothelin epitope aa540-549 (pcDNA3-Hmeso540-beta 2m-A2) generated strong human mesothelin peptide (aa540-549)-specific CD8(+) T cell immune responses in HLA-A2 transgenic mice. Vaccination with pcDNA3-Hmeso540-beta 2m-A2 prevented the growth of HLA-A2 positive human mesothelin-expressing tumor cell lines in HLA-A2 transgenic mice in contrast to vaccination with DNA encoding SCT linked to OVA CTL epitope. Thus, the employment of SCT of HLA-A2 linked to the human mesothelin epitope aa540-549 represents a potential opportunity for the clinical translation of DNA vaccines against human mesothelin-expressing tumors, particularly ovarian cancer cells. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:127 / 135
页数:9
相关论文
共 17 条
[1]  
[Anonymous], 1992, Lancet
[2]   Antigenic drift as a mechanism for tumor evasion of destruction by cytolytic T lymphocytes [J].
Bai, XF ;
Liu, JQ ;
Li, O ;
Zheng, P ;
Liu, Y .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (10) :1487-1496
[3]  
BAUM M, 1990, ADJUVANT THERAPY CAN, V6, P269
[4]  
Boyd DAK, 2003, IDRUGS, V6, P1155
[5]  
Chen CH, 2000, CANCER RES, V60, P1035
[6]   MUTATIONAL ANALYSIS OF THE ASSEMBLY DOMAIN OF THE HIV-1 ENVELOPE GLYCOPROTEIN [J].
EARL, PL ;
MOSS, B .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (07) :589-594
[7]   Cancer immunotherapy using a DNA vaccine encoding a single-chain trimer of MHC class I linked to an HPV-16 E6 immunodominant CTL epitope [J].
Huang, CH ;
Peng, S ;
He, L ;
Tsai, YC ;
Boyd, DAK ;
Hansen, TH ;
Wu, TC ;
Hung, CF .
GENE THERAPY, 2005, 12 (15) :1180-1186
[8]  
Hung CF, 2003, CURR OPIN MOL THER, V5, P20
[9]  
Lin KY, 1996, CANCER RES, V56, P21
[10]   Induction of protective immunity to Listeria monocytogenes by immunization with plasmid DNA expressing a helper T-cell epitope that replaces the class II-associated invariant chain peptide of the invariant chain [J].
Nagata, T ;
Aoshi, T ;
Suzuki, M ;
Uchijima, M ;
Kim, YH ;
Yang, ZB ;
Koide, Y .
INFECTION AND IMMUNITY, 2002, 70 (05) :2676-2680